Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
AOD 9604 clinical evidence The most rigorous AOD 9604 data comes from the Metabolic Pharmaceuticals clinical program conducted between 2001 and 2007
Unlike HGH, AOD 9604 has no growth-promoting effects, which makes it safer to use as part of a targeted therapy plan
This comprehensive analysis examines the clinical trial evidence for AOD-9604s safety profile, including participant numbers, study designs, reported adverse effects, metabolic safety markers, immunogenicity data, and how this peptides safety characteristics compare to related therapies
discard if color fades significantly Injectable reconstituted: Refrigerate
Australian Securities Exchange filing, February 2007
When Direct Medical Supervision Is Required While many can manage their injections, some need direct medical supervision
US$ 25.52
US$ 26.21
US$ 27.86
US$ 27.65
US$ 25.25
US$ 27.65
US$ 20.71
US$ 21.49
US$ 27.74
US$ 21.86
US$ 24.99
US$ 22.82
US$ 23.57
